Jefferies Group reiterated their hold rating on shares of Smiths Group (LON:SMIN) in a research note issued to investors on Thursday. The brokerage currently has a GBX 1,575 ($21.76) price target on the stock.
A number of other equities research analysts have also recently commented on SMIN. Barclays began coverage on shares of Smiths Group in a research report on Tuesday, February 13th. They set an overweight rating and a GBX 1,800 ($24.87) target price for the company. Numis Securities reissued a hold rating and set a GBX 1,600 ($22.11) target price on shares of Smiths Group in a research report on Tuesday, December 5th. Credit Suisse Group reissued an outperform rating and set a GBX 1,730 ($23.90) target price on shares of Smiths Group in a research report on Friday, December 8th. Deutsche Bank reissued a buy rating and set a GBX 1,750 ($24.18) target price on shares of Smiths Group in a research report on Monday, December 4th. Finally, JPMorgan Chase & Co. reaffirmed an overweight rating and issued a GBX 1,800 ($24.87) price target on shares of Smiths Group in a report on Monday, January 15th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. The stock currently has an average rating of Buy and an average target price of GBX 1,753.50 ($24.23).
Smiths Group (LON:SMIN) traded up GBX 1.50 ($0.02) during trading hours on Thursday, reaching GBX 1,591 ($21.98). 281,213 shares of the company were exchanged, compared to its average volume of 1,370,000. Smiths Group has a 12 month low of GBX 1,442 ($19.92) and a 12 month high of GBX 1,697 ($23.45). The stock has a market capitalization of $6,300.00 and a PE ratio of 1,120.42.
In related news, insider George Buckley purchased 782 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was acquired at an average price of GBX 1,599 ($22.09) per share, with a total value of £12,504.18 ($17,275.74).
COPYRIGHT VIOLATION WARNING: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/23/smiths-groups-smin-hold-rating-reaffirmed-at-jefferies-group.html.
Smiths Group Company Profile
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.